Author Archives: Beverley Snell

GSK China fined record sum

(Published 22 September 2014) Cite this as: BMJ 2014;349:g5799 Jane Parry GlaxoSmithKline’s China operation has been fined $488 million after being found guilty of bribery by the Changsha Intermediate People’s Court in Hunan province. In the closed door trial, which … Continue reading

Posted in Uncategorized | Leave a comment

Public health in danger with move of pharmaceutical policy to DG Enterprise and Industry

12 September, 2014 www.haieurope.org Health Action International is appalled by the European Commission’s opaque and unjustified decision to move SANCO Units D5 (Medicinal Products–Authorisations, European Medicines Agency) and D6 (Medicinal Products–Quality, Safety and Efficacy) from the Directorate General (DG) for … Continue reading

Posted in Uncategorized | Leave a comment

Falsified medicines in Africa: all talk, no action

Paul N Newton et al The Lancet Global Health, Volume 2, Issue 9, Pages e509 – e510, September 2014 Poor-quality medicines and medical products, both substandard and falsified, cause avoidable morbidity, mortality, drug resistance, and loss of faith in health systems, … Continue reading

Posted in Uncategorized | Leave a comment

Declaring all – Jane McCredie in MJAInsight

From MJAInsight, Monday August 25, 2014 Medical researchers are rightly required to declare potential financial conflicts of interest when they publish their results, but what of other, more personal, factors that might lead to bias in their findings? Should, for … Continue reading

Posted in Uncategorized | Leave a comment

Doctors under the influence

From Zoe Stewart in MJAInsight,  Monday, 25 August, 2014 A recent research article found that medical students and junior doctors exposed to information from pharmaceutical companies were more likely to refer to drugs using their brand names. The authors used a survey to … Continue reading

Posted in Uncategorized | Leave a comment

WHO and partners launch Ebola response plan

A multimillion dollar international strategy to bring west Africa’s Ebola outbreak under control was launched by WHO and countries last week. www.thelancet.com Vol 384 August 9, 2014 Read more here Frequently asked questions here

Posted in Uncategorized | Leave a comment

AIDS 2014 Melbourne, July 20-25

Friday July 25, 2014 – AIDS 2014, the 20th International AIDS Conference ended in Melbourne, Australia with a chorus of international figures calling on governments and organisations to step up the pace in terms of delivering universal access to treatment, … Continue reading

Posted in Uncategorized | Leave a comment

Malaysia: Anti-TPPA movement to come out with book on the controversial agreement

Source: http://www.themalaysianinsider.com/malaysia/article/anti-tppa-movement-to-comeout-with-book-on-the-controversial-agreement#sthash.VdvccdgO.dpuf 10 July 2014 Malaysia’s anti-Trans Pacific Partnership Agreement (TPPA) movement is putting out a book as part of its protest against the pact despite confirmation from Putrajaya that Malaysia would go ahead with the controversial Pacific Rim trade … Continue reading

Posted in Uncategorized | Leave a comment

The Trans Pacific Partnership Agreement: Implications for Access to Medicines and Public Health – UNITAID

Final Report UNITAID March 2014 Through this analysis of provisions that are proposed in the context of the Trans-Pacific Partnership Agree­ment negotiations, UNITAID seeks to better understand current and future issues in trade negotiations and their impact on access to … Continue reading

Posted in Uncategorized | Leave a comment

TPP – Failure to agree again

Little to gain and much to lose in the Trans-Pacific Partnership (TPP) By Jemma Williams Trade Ministers from 12 countries around the Pacific Rim met once again in Singapore on May 19-20. Their aim was a breakthrough in negotiations towards the … Continue reading

Posted in Uncategorized | Leave a comment